AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Cyclo Therapeutics to Present at BIOTECH SHOWCASE™ 2020 in San Francisco

January 7, 2020 GMT

GAINESVILLE, Fla.--(BUSINESS WIRE)--Jan 7, 2020--

Cyclo Therapeutics, Inc. (OTCQB: CTDH), a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C (NPC) and Alzheimer’s Disease, today announced that N. Scott Fine, Chairman and Chief Executive Officer, and other members of the management team will represent the company at Biotech Showcase™ 2020, to be held January 13–15 at the Hilton San Francisco Union Square, 3330 O’Farrell Street, San Francisco, CA 94102.

Cyclo Therapeutics is scheduled to present:

Monday, January 13, 2020,

10:00 a.m. to 10:30 a.m. PST.

Individuals who cannot attend the meeting in person can find webcast information at: www.cyclotherapeutics.com. A replay will also be available following the meeting.

About Cyclo Therapeutics:

Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The company’s Trappsol ®  Cyclo™, an orphan drug designated product in the United States and Europe, is in three ongoing formal clinical trials for Niemann-Pick Disease Type C, a rare and fatal genetic disease (ClinicalTrials.gov NCT02939547, NCT02912793 and NCT03893071 ), and in an Expanded Access program for late-onset Alzheimer’s Disease ( NCT03624842 ). Additional indications for the active ingredient in Trappsol ®  Cyclo™ are in development. For additional information, visit the company’s website:  www.cyclotherapeutics.com

About BIOTECH SHOWCASE:

Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather in San Francisco during this bellwether week which sets the tone for the coming year. Now in its 12th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200107005162/en/

CONTACT: RedChip Companies, Inc.

Victor Roberts

407-571-0909

victor@redchip.com

KEYWORD: UNITED STATES NORTH AMERICA FLORIDA

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL MEDICAL SUPPLIES

SOURCE: Cyclo Therapeutics, Inc.

Copyright Business Wire 2020.

PUB: 01/07/2020 08:00 AM/DISC: 01/07/2020 08:01 AM

http://www.businesswire.com/news/home/20200107005162/en